Please assess the completion status of the following clinical trial:

Trial Title: Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Solid malignancy of any type~* Patients must be scheduled to receive their first dose of paclitaxel at Vanderbilt-Ingram Cancer Center~  * Any paclitaxel-containing regimen or dosing schedule is allowed~PATIENT CHARACTERISTICS:~* Not pregnant~* Accessible for follow-up~* Able to submit urine samples~* Able to complete questionnaires~PRIOR CONCURRENT THERAPY:~* See Disease Characteristics

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Paclitaxel-Induced Myalgias/Arthralgias (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).